We've found
184,457
clinical trials
Stress Urinary Incontinence Clinical Trial
The Effect of Pudendal Blocks on Voiding Dysfunction Following Slings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Obesity Clinical Trial
Timing of Eating Study Among Obese Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Status: Enrolling,
Phase
I, II
Updated: 3/20/2018
Click here to add this to my saved trials
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox Gastaut Syndrome Clinical Trial
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology Clinical Trial
2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diffuse B-Cell Lymphoma Clinical Trial
Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Choroideremia Clinical Trial
Natural History of the Progression of Choroideremia Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Reproductive Clinical Trial
Nurse-Family Partnership Impact Evaluation in South Carolina
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Reproductive Clinical Trial
Nurse-Family Partnership Impact Evaluation in South Carolina
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Infection Clinical Trial
Does a Safety Difference Exist Between IV Push and IV Piggyback Antibiotics?
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Study of Emicizumab Prophylaxis in Participants With Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Study of Emicizumab Prophylaxis in Participants With Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Failure Aggravated Clinical Trial
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
PRS-343 in HER2-Positive Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Neuroimaging of Anesthetic Modulation of Human Consciousness
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis B Clinical Trial
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Computer-based Intervention for Alcohol-using HIV/HCV+ Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lumbosacral Radicular Pain Clinical Trial
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lumbosacral Radicular Pain Clinical Trial
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Stress Urinary Incontinence Clinical Trial
Updated: 12/31/1969
The Effect of Pudendal Blocks on Voiding Dysfunction Following Slings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Obesity Clinical Trial
Updated: 12/31/1969
Timing of Eating Study Among Obese Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/20/2018
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Status: Enrolling,
Phase
I, II
Updated: 3/20/2018
Click here to add this to my saved trials
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Updated: 12/31/1969
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Updated: 12/31/1969
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Updated: 12/31/1969
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Updated: 12/31/1969
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox Gastaut Syndrome Clinical Trial
Updated: 12/31/1969
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology Clinical Trial
Updated: 12/31/1969
2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diffuse B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Choroideremia Clinical Trial
Updated: 12/31/1969
Natural History of the Progression of Choroideremia Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
Updated: 12/31/1969
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Updated: 12/31/1969
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy, Focal Seizures, Partial Seizures Clinical Trial
Updated: 12/31/1969
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Reproductive Clinical Trial
Updated: 12/31/1969
Nurse-Family Partnership Impact Evaluation in South Carolina
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Reproductive Clinical Trial
Updated: 12/31/1969
Nurse-Family Partnership Impact Evaluation in South Carolina
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Infection Clinical Trial
Updated: 11/30/2017
Does a Safety Difference Exist Between IV Push and IV Piggyback Antibiotics?
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Updated: 12/31/1969
Study of Emicizumab Prophylaxis in Participants With Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Updated: 12/31/1969
Study of Emicizumab Prophylaxis in Participants With Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiac Failure Aggravated Clinical Trial
Updated: 12/31/1969
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients With Worsening Heart Failure
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
PRS-343 in HER2-Positive Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 12/31/1969
Neuroimaging of Anesthetic Modulation of Human Consciousness
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Updated: 12/31/1969
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Computer-based Intervention for Alcohol-using HIV/HCV+ Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Updated: 12/31/1969
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Updated: 12/31/1969
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure; With Decompensation Clinical Trial
Updated: 12/31/1969
Heart Sounds Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
Updated: 12/31/1969
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Updated: 12/31/1969
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Updated: 12/31/1969
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Updated: 12/31/1969
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lumbosacral Radicular Pain Clinical Trial
Updated: 12/31/1969
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lumbosacral Radicular Pain Clinical Trial
Updated: 12/31/1969
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials